CIK 0000899923
- Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 870494517
- Phone
- +1 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- 4 Grant or award Chief Financial Officer acquired 60,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Insider Changes in Ownership
- 4 Grant or award Director acquired 49,796 shares (grant or award)
- 4 Grant or award Director acquired 49,796 shares (grant or award)
- 4 Grant or award Director acquired 24,148 shares (grant or award)
- 4 Grant or award Director acquired 49,796 shares (grant or award)
- 4 Grant or award Director acquired 49,796 shares (grant or award)
- 4 Grant or award Director acquired 49,796 shares (grant or award)
- 4 Grant or award Director acquired 49,796 shares (grant or award)
- 4 Grant or award Director acquired 49,796 shares (grant or award)
- 4 Grant or award President and CEO acquired 1,498 shares (grant or award)
- 4 Grant or award Chief Commerical Officer acquired 397,534 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Insider Changes in Ownership
- 4 Shares withheld for taxes Chief Scientific Officer gave up 942 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Commercial Officer gave up 1,085 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 362 shares (to pay taxes)
Page 4 of 65 · 1,293 filings